Patients with checkpoint inhibitor‐induced inflammatory arthritis do not become seropositive for anti‐cyclic citrullinated peptide when followed over time by Laura C. Cappelli, Erika Darrah, Ami A. Shah, Clifton O. Bingham

Get full text

Anti–Peptidylarginine Deiminase 4 Autoantibodies and Disease Duration as Predictors of Treatment Response in Rheumatoid Arthritis by Laura C. Cappelli, David Hines, Hong Wang, Clifton O. Bingham, Erika Darrah

Get full text

Sonographic Findings in Inflammatory Arthritis Secondary to Immune Checkpoint Inhibition: A Case Series by Jemima Albayda, Eric Dein, Ami A. Shah, Clifton O. Bingham III, Laura Cappelli

Get full text

Smoking is not linked to the development of anti-peptidylarginine deiminase 4 autoantibodies in rheumatoid arthritis by Laura C. Cappelli, Maximilian F. Konig, Allan C. Gelber, Clifton O. Bingham, Erika Darrah

Get full text

Response to Treatment with Intravenous Golimumab or Infliximab in Rheumatoid Arthritis Patients: PROMIS Results from the Real-World Observational Phase 4 AWARE Study by Clifton O. Bingham, Shawn Black, Natalie J. Shiff, Stephen Xu, Wayne Langholff, Jeffrey R. Curtis

Get full text

The impact of tofacitinib on fatigue, sleep, and health-related quality of life in patients with rheumatoid arthritis: a post hoc analysis of data from Phase 3 trials by Susan J. Bartlett, Clifton O. Bingham, Ronald van Vollenhoven, Christopher Murray, David Gruben, David A. Gold, David Cella

Get full text

Machine Learning Applied to Patient‐Reported Outcomes to Classify Physician‐Derived Measures of Rheumatoid Arthritis Disease Activity by Jeffrey R. Curtis, Yujie Su, Shawn Black, Stephen Xu, Wayne Langholff, Clifton O. Bingham, Shelly Kafka, Fenglong Xie

Get full text

The effect of tofacitinib on residual pain in patients with rheumatoid arthritis and psoriatic arthritis by Maxime Dougados, Peter C Taylor, Clifton O Bingham, Lisy Wang, Lara Fallon, Satrajit Roychoudhury, Yves Brault, Meriem Kessouri

Get full text

Association between low hemoglobin, clinical measures, and patient-reported outcomes in patients with rheumatoid arthritis: results from post hoc analyses of three phase III trials... by Andrea Rubbert-Roth, Daniel E. Furst, Stefano Fiore, Amy Praestgaard, Vivian Bykerk, Clifton O. Bingham, Christina Charles-Schoeman, Gerd Burmester

Get full text

Treatment goals for rheumatoid arthritis: patient engagement and goal collection by Zachary Predmore, Emily K Chen, Thomas W Concannon, Suzanne Schrandt, Susan J Bartlett, Clifton O Bingham, Richard Z Xie, Richard H Chapman, Lori Frank

Correction to: Use of daily electronic patient-reported outcome (PRO) diaries in randomized controlled trials for rheumatoid arthritis: rationale and implementation by Clifton O. Bingham, Carol L. Gaich, Amy M. DeLozier, Kathryn D. Engstrom, April N. Naegeli, Stephanie de Bono, Pixy Banerjee, Peter C. Taylor

Get full text

Use of daily electronic patient-reported outcome (PRO) diaries in randomized controlled trials for rheumatoid arthritis: rationale and implementation by Clifton O. Bingham, Carol L. Gaich, Amy M. DeLozier, Kathryn D. Engstrom, April N. Naegeli, Stephanie de Bono, Pixy Banerjee, Peter C. Taylor

Get full text

Anti-RA33 antibodies are present in a subset of patients with immune checkpoint inhibitor-induced inflammatory arthritis by Laura C Cappelli, Clifton O Bingham, Patrick M Forde, Evan J Lipson, Megan Schollenberger, Ami A Shah, Julie Brahmer, Valsamo Anagnostou, Erika Darrah, Jennifer Mammen

Get full text

Autoantibodies to Peptidylarginine Deiminase 2 Are Associated With Less Severe Disease in Rheumatoid Arthritis by Erika Darrah, Jon T. Giles, Ryan L. Davis, Pooja Naik, Hong Wang, Maximilian F. Konig, Laura C. Cappelli, Clifton O. Bingham, Sonye K. Danoff, Felipe Andrade

Get full text

Citrullination modulates antigen processing and presentation by revealing cryptic epitopes in rheumatoid arthritis by Ashley M. Curran, Alexander A. Girgis, Yura Jang, Jonathan D. Crawford, Mekha A. Thomas, Ryan Kawalerski, Jeff Coller, Clifton O. Bingham, Chan Hyun Na, Erika Darrah

Get full text

Immune-related adverse events with immune checkpoint inhibitors affecting the skeleton: a seminal case series by Kendall F. Moseley, Jarushka Naidoo, Clifton O. Bingham, Michael A. Carducci, Patrick M. Forde, Geoffrey T. Gibney, Evan J. Lipson, Ami A. Shah, William H. Sharfman, Laura C. Cappelli

Get full text

PROMIS Fatigue short forms are reliable and valid in adults with rheumatoid arthritis by Clifton O. Bingham III, Anna Kristina Gutierrez, Alessandra Butanis, Vivian P. Bykerk, Jeffrey R. Curtis, Amye Leong, Anne Lyddiatt, W. Benjamin Nowell, Ana Maria Orbai, Susan J. Bartlett

Get full text

Physician Views on the Provision of Information on Immune Checkpoint Inhibitor Therapy to Patients with Cancer and Pre-Existing Autoimmune Disease: A Qualitative Study by Maria A. Lopez-Olivo, Gabrielle F. Duhon, Juan I. Ruiz, Mehmet Altan, Hussein Tawbi, Adi Diab, Clifton O. Bingham, Cassandra Calabrese, Natalia I. Heredia, Robert J. Volk, Maria E. Suarez-Almazor

Get full text

The trajectory of clinical responses in patients with early rheumatoid arthritis who achieve sustained remission in response to abatacept: subanalysis of AVERT-2, a randomized phas... by Paul Emery, Yoshiya Tanaka, Vivian P. Bykerk, Clifton O. Bingham, Thomas W. J. Huizinga, Gustavo Citera, Kuan-Hsiang Gary Huang, Chun Wu, Sean E. Connolly, Yedid Elbez, Robert Wong, Karissa Lozenski, Roy Fleischmann

Get full text

292 Fibromyalgianess and Glucocorticoid Persistence Among Patients with Rheumatoid Arthritis by Beth Wallace, Meriah N. Moore, Andrew C. Heisler, Lutfiyya N. Muhammad, Jing Song, Daniel J. Clauw, Clifton O. Bingham, Marcy B. Bolster, Wendy Marder, Tuhina Neogi, Alyssa Wohlfahrt, Dorothy D. Dunlop, Yvonne C. Lee

Get full text